The impact of the UK COVID-19 lockdown on the screening, diagnostics and incidence of breast, colorectal, lung and prostate cancer in the UK: a population-based cohort study
<p><b>Introduction:</b> The COVID-19 pandemic had collateral effects on many health systems. Cancer screening and diagnostic tests were postponed, resulting in delays in diagnosis and treatment. This study assessed the impact of the pandemic on screening, diagnostics and incidence...
Auteurs principaux: | Barclay, NL, Pineda Moncusí, MP, Jödicke, AM, Prieto-Alhambra, D, Raventós, B, Newby, D, Delmestri, A, Man, WY, Chen, X, Català, M |
---|---|
Autres auteurs: | The OPTIMA Consortium |
Format: | Journal article |
Langue: | English |
Publié: |
Frontiers Media
2024
|
Documents similaires
-
The impact of the UK COVID-19 lockdown on the screening, diagnostics and incidence of breast, colorectal, lung and prostate cancer in the UK: a population-based cohort study
par: Nicola L. Barclay, et autres
Publié: (2024-03-01) -
Collateral effects of the COVID-19 pandemic on endocrine treatments for breast and prostate cancer in the UK: a cohort study
par: Barclay, NL, et autres
Publié: (2024) -
Incidence, prevalence, and survival of prostate cancer in the UK
par: Tan, EH, et autres
Publié: (2024) -
Collateral effects of the COVID-19 pandemic on endocrine treatments for breast and prostate cancer in the UK: a cohort study
par: Nicola L. Barclay, et autres
Publié: (2024-06-01) -
Risk of falls following the initiation of antihypertensives in the elderly: a self-controlled case series in the UK
par: Jödicke, AM, et autres
Publié: (2021)